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Regulation of plasma aldosterone concentration in anephric
man and renal transplant recipients. Regulatory factors con-
trolling plasma aldosterone in the anephric state were further
examined in bilaterally nephrectomized patients and renal trans-
plant recipients. The effect of supine and upright posture on the
concentration of plasma aldosterone, and the possible role of
potassium in these responses in the anephric patients, was
studied on the first and either the third or fourth day post-
dialysis (anephric patients) and during periods of high and low
sodium intake (renal transplant recipients). As previously re-
ported, a significant correlation between plasma aldosterone and
serum potassium concentration (r=0.871, P<0.001) could be
demonstrated in anephric patients. In addition, the present
studies demonstrate that in a single anephric individual, changes
in serum potassium concentration are associated with concor-
dant alterations in plasma aldosterone concentration (r value
for A plasma aldosterone concentration in anephric patients on
the third or fourth day post-dialysis was 0.911, P< 0.005).
Changes in posture from supine to upright produced no change
in the concentration of plasma aldosterone in the anephric
patients that could not be attributed to variations in the serum
potassium concentration. In contrast, the plasma aldosterone
concentration in renal transplant recipients increased significantly
after two hours of ambulation during both high and low sodium
intake, and was correlated with plasma renin activity (PRA).
These studies demonstrate that plasma aldosterone, in the
absence of the kidneys, is unresponsive to postural variation
under conditions in which significant changes in plasma aldo-
sterone concentrations are observed in renal transplant recipients.
Thus, additional evidence indicating that changes in potassium
rather than volume-related stimuli are the primary regulator of
plasma aldosterone in anephric patients is provided.
Regulation de la concentration plasmatique d'aldostérone au
cours de l'anéphrie et aprés Ia transplantation rénale. Les facteurs
régulateurs contrôlant Ia secretion d'aldostérone au cours de
l'anéphrie ont été étudiés chez des malades ayant subi une
néphrectomie bilatérale et chez des transplantés. L'effet de la
position couchée ou debout sur Ia concentration plasmatique
d'aldostérone et le role possible du potassium dans ces rOponses
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chez le malade anéphrique ont été étudiés le premier et le troi-
siéme ou quatriéme jour aprés dialyse (malades anéphriques) et
durant des périodes de régime riche puis pauvre en sodium
(receveurs de reins transplantés). Ainsi que nous l'avons an-
térieurement rapporté il existe une correlation significative entre
les concentrations plasmatiques d'aldostérone et de potassium
(r= 0,871; P< 0,001) chez le malade anéphrique. De surcroIt,
l'étude actuelle démontre que chez un méme sujet anéphrique
les modifications de la concentration du potassium sont asso-
ciées a des modifications concordantes de Ia concentration plas-
matique d'aldostérone (le r de Ia correlation A du potassium
plasmatique avec A d'aldostérone plasmatique chez le sujet
anéphrique le troisiéme ou le quatriême jour post dialyse est
égal a 0,911; P< 0,005). Le passage de Ia position couchée a Ia
position debout ne produit pas de modification de l'aldosterone
plasmatique, chez les sujets anéphriques, qui ne pourraient étre
attribués aux modifications du potassium plasmatique. Al'op-
pose, l'aldostérone plasmatique chez les transplantes augmente
significativement aprés 2 heures d'ambulation, que le régime soit
riche ou pauvre en sel, et elle est correlée avec l'activité rénine
plasmatique. Ces résultats démontrent que Ia secretion d'aldo-
stérone, en l'absence de reins, ne répond pas auxh modifications
posturales dans des conditions ots des modifications significa-
tives de la concentration plasmatique d'aldostérone sont oh-
servées chex les sujets transplantés. Ainsi des arguments supple-
mentaires indiquent que les modifications de potassium, plus
que des stimuli volémiques, sont le facteur primaire de Ia régu-
lation de Ia secretion d'aldostérone chez l'anéphrique.
In previous studies on bilaterally nephrectomized
patients, we observed a significant correlation between the
concentration of plasma aldosterone and the serum
potassium concentration but we could not demonstrate
consistent changes in the concentration of plasma aldo-
sterone in response to changes in posture and sodium
balance [1]. Recently, Mitra et al [2] reported an increase
in the concentration of plasma aldosterone in anephric
patients after two hours of quiet standing associated with a
significant reduction of mean arterial blood pressure. In
a preliminary communication, McCaa et al [3] also reported
an increase in the concentration of plasma aldosterone in
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anephric patients following acute sodium and volume
depletion produced by hemodialysis. However, gradual
volume depletion produced by hypertonic peritoneal
dialysis was not associated with an increase in the con-
centration of plasma aldosterone in the studies of Mitra
et al [2].
In the present studies, we have extended our observations
on bilaterally nephrectomized patients and have examined
the role of potassium in any changes in the concentration
of plasma aldosterone noted in relation to postural variation.
In addition, since studies on renal transplant recipients
have shown that renin is released by the transplanted
kidney [4—6] and that renin responses to changes in posture
and sodium intake resemble those of normal individuals
[7—9], we have studied the effects of upright posture and
ambulation on the concentration of plasma aldosterone in
a group of transplant recipients and have compared the
responses noted to those of the anephric patients who have
no detectable PRA, or, at least, in whom the renin-angio-
tensin system appears to be functionally absent.
Methods
Studies on anephric patients. Studies were performed on
12 anephric patients, five females and seven males, ranging
in age from 15 to 52 years. All patients, with one exception
(T. G.), were studied both on the first day postdialysis and
the third or fourth day postdialysis. The patients were
studied on both occasions while in the supine position,
before arising in the morning, and after two hours of normal
ambulation. Dietary sodium and potassium intake in the
interval between the studies (first day to third or fourth
day postdialysis) was only moderately restricted; change
in body weight and serum sodium concentration served as
indices of sodium intake. In the two-hour interval between
the supine and postambulatory studies, the patients
remained fasting. The techniques employed in the col-
lection of blood samples and separation of plasma for
determinations of PRA and plasma aldosterone concentra-
tion have been described previously [11. Blood samples
were also obtained for determination of serum potassium
concentration (supine and postambulatory).
Studies on renal transplant recipients. Eleven renal
transplant recipients, five females and six males, were
studied; the age range was 16 to 53 years. The post-
transplant interval prior to the studies was 3 to 17 months.
Seven patients received kidneys from cadaveric donors and
four received kidneys from a sibling. The prednisone
dosages were 15 or 20 mg/day for all recipents of cadaveric
kidneys and 10 mg/day for one recipient of a sibling kidney.
The other recipients of sibling kidneys were treated with
azathioprine only. All patients were studied while on a
high sodium intake (regular diet plus 6 g of sodium
chloride per day for five days) and on the fifth day of a
period of restricted sodium intake (less than 17 mEq of
sodium per day). The estimated potassium intake in both
periods was 60 to 80 mEq per day. Blood samples were
obtained at the end of both study periods for determination
of PRA and plasma aldosterone concentration in the
supine position and after two hours of normal ambulation.
Additional blood samples were collected for determinations
of serum sodium, potassium and creatinine concentrations.
Analytical methods. Analytical methods and sensitivities
have been described previously [1, 10]. PRA in six plasma
samples from three anephric patients (A.D., D.J. and
D. W.) was determined by bioassay. All the other plasma
samples were analyzed for PRA by radioimmunoassay.
For statistical purposes, detectable PRA lower than 0.2 ng
angiotensin I generated/ml plasma/hr and plasma aldo-
sterone lower than 0.5 ng/lOO ml plasma are arbitrarily
reported as 0.2 ng and 0.5 ng respectively.
Results
Studies on anephric patients. Data on PRA, plasma
aldosterone concentration and serum potassium concentra-
tion are shown in Tables 1 (first day postdialysis) and 2
Table 1. Data from anephric patients
studied on the first day postdialysis
Patient PRA
ng/ml/hr
Supine Upright
Plasma
aldosterone
ng/100 ml
Supine Upright
Serum K
mEq/liter
Supine Upright
A.D. ND NDa 0.5 0.5 4.6 5.0
D.J. ND NDa 0.6 0.6 3.8 —
E.S. ND ND 1.0 1.3 4.8 4.8
H.S. ND 0.2 0.8 0.5 — 4.4
D.W. NDa NDa 2.8 2.7 5.1 4.8
P.C. ND ND 1.8 1.2 4.7 4.9
R.A. ND ND 0.5 3.4 4.6 3.1
B.G. ND ND 2.3 3.5 4.4 5.3
T.G. ND ND 3.7 5.2 3.5 3.4
J.W. ND ND 1.6 0.9 4.1 3.9
Mean 1.6 2.0 4.4 4.4
SD 0.9 1.6 0.6 0.9
ND = PRA not detectable by the assay procedures.
a PRA determined by bioassay (ng angiotensin II formed/mi
plasma/br).
(third or fourth day postdialysis).' PRA could be detected
in only one patient, H. S., on the first day postdialysis and
in two patients, D.J. and B.G., on the third or fourth day
postdialysis. No effect of upright posture (two hours of
ambulation) on the concentration of plasma aldosterone
(supine vs. upright) could be demonstrated on either the
Data from the studies on A.D., D.J., E.S., H.S., D.W., H.G.
and J.Ba. were previously reported [1]. Only the studies (first
day or third or fourth day postdialysis) in which both supine
and postambulatory values were obtained are included in the
present report.
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Table 2. Data from anephric patients
studied on the third or fourth day postdialysis
Patient PRA
ng/mI/hr
Supine Upright
Plasma
aldosterone
ng/100 ml
Supine Upright
Serum K
mEq/liter
Supine Upright
H.G. ND ND 0.5 1.0 4.9 —
D.J. 3.Oa ND 6.6 10.9 6.0 5.9
E.S. ND ND 3.9 3.9 5.0 4.5
J.Ba. ND ND 41.4 60.2 6.9 7.7
D.W. ND ND 10.4 8.3 6.3 —
P.C. ND ND 15.3 2.3 6.0 4.8
R.A. ND ND 17.0 12.5 6.4 5.1
B.G. ND 0.5 15.6 9.5 5.5 5.0
J.W. ND ND 1.4 4.6 5.1 5.2
Mean 12.5 12.6 5.8 5.5
SD
ND =PRA not detectable by the assay procedures.
a PRA determined by bioassay (ng angiotensin II formed/mi
plasma/br).
Fig. 2. Differences between supine and postambulatory plasma
aldosterone concentrations on the third or fourth day postdialysis
correlated with the differences between the supine and postambu-
latory serum potassium concentrations.
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P<0.001
first day postdialysis (P>0.2) or the third or fourth day
postdialysis (F> 0.6). However, the concentrations detected
on the third or fourth day postdialysis, compared to those
in the same patients on the first day postdialysis, were This increase in the concentration of plasma aldosterone
significantly increased (supine, F'<0.02; upright, F<0.01). occurred despite an increase in body weight (0.9, SEM
0.2 kg in the patients with paired data shown in both
60 Table 1 and Table 2).
The serum potassium concentration in the supine
position increased significantly between the first day post-
dialysis and the third or fourth day postdialysis (P<0.005).
50 After two hours of ambulation, the serum potassium
concentration was not significantly altered (first day,
F>0.7; third or fourth day, P>0.2), although individual
40 variations in the concentration between supine and post-
ambulatory patients were greater on the third or fourth
day postdialysis than on the first day postdialysis. As
shown in Fig. 1, there was a highly significant correlation
30 (r=0.871, P<0.OOl) between the serum potassium con-
centrations (supine and upright) and the plasma aldosterone
concentrations (supine and upright) on the third or fourth
day postdialysis. More convincing evidence that serum
20 potassium concentration is a major factor in the regulation
of plasma aldosterone concentration is obtained by com-
paring changes in serum potassium concentration in the
10 individual anephric patient with corresponding changes in
plasma aldosterone concentration. The correlation between
the changes in serum potassium concentration and the
corresponding changes in plasma aldosterone concentration
0 .i in each anephric patient for whom complete data are
8.0 available in Table 2 (Fig. 2) is highly significant (r =0.911,
P<0.005), indicating that, in the anephric individual, both
increases and decreases in serum potassium concentration
are associated with concordant changes in plasma aldo-
sterone concentration. These correlations were not demon-
.
V.
.
4.0 5.0 6.0 7.0
Serum potassium, mEq/liter
Fig. 1. Correlation of plasma aldosterone concentration with serum
potasssium concentration, supine and postambulatory values, on the
third or fourth day postdialysis.
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Table 3. Data from renal transplant recipients studied while on a high sodium intake
Patient PRA Plasma aldosterone Serum K Serum Body
creatinine weight
ng/ml/hr ng/100 ml mEq/liter mg/100 ml kg
Supine Upright Supine Upright
J.Br. 0.2 3.8 1.6 8.0 3.9 1.3 60.9
D.W. 0.2 1.4 0.6 0.5 4.0 1.5 40.0
S.M. ND ND 4.2 2.8 4.2 1.0 63.2
F.A. 0.5 2.3 8.7 7.7 4.0 1.3 96.0
A.S. ND 2.9 — 37.5 3.3 1.1 76.9
D.M. 0.3 1.4 2.3 17.6 2.8 1.0 63.8
R.A. 0.5 2.4 1.3 21.0 3.9 1.0 79.4
P.K. ND 0.6 4.0 34.0 4.5 1.0 44.0
M.C.a 0.2 0.2 2.4 0.5 4.6 1.4 54.3
P.C.a 0.2 1.3 2.6 26.2 4.3 0.9 68.9
H.G.a — 0.2 3.4 33.8 5.1 1.0 44.2
Mean 0.2 1.5 3.1 17.2 4.1 1.1 62.9
SD 0.16 1.3 2.2 14.3 0.7 0.3 16.9
ND = PRAnot detectable.
a Recipients of sibling kidneys.
Table 4. Data from renal transplant recipients studied while on a low sodium intake
Patient PRA Plasma aldosterone Serum K Serum Body
creatinine weight
ng/ml/hr ng/JOO ml mEq/liter mg/100 ml kg
Supine Upright Supine Upright
J.Br. 3.5 18.9 4.0 50.0 4.3 1.2 59.7
D.W. 1.3 4.5 2.0 7.0 3.5 1.5 39.7
S.M. 1.7 2.2 4.1 48.0 4.1 1.0 61.3
F.A. 1.2 2.7 8.6 9.4 4.4 1.4 90.1
A.S. 1.2 2.6 30.9 53.0 4.0 0.9 74.3
D.M. 1.6 2.2 20.1 37.5 2.9 1.0 61.6
R.A. 0.8 3.0 2.3 48.5 4.1 1.1 78.4
P.K. 2.4 2.2 22.0 70.7 4.4 1.1 42.6
M.Ca 0.9 1.6 14.5 31.0 4.4 1.6 52.2
P.C.a 1.3 3.2 39.5 34.2 3.9 1.0 66.3
H.G.a 0.6 0.7 32.1 65.3 4.7 1.0 43.7
Mean 1.5 4.0 16.4 41.3 4.1 1.2 60.9
SD 0.7 5.0 13.6 20.2 0.7 0.3 15.9
a Recipients of sibling kidneys.
strable in the presence of lower serum potassium and
plasma aldosterone concentrations on the first day post-
dialysis.
Studies on renal transplant recipients. Data from the
studies on the renal transplant recipients are shown in
Tables 3 and 4. The increase in PRA and plasma aldo-
sterone concentration induced by upright activity was
significant in both the period of high sodium intake (PRA,
P<0.005; plasma aldosterone, P<0.01) and the period
of low sodium intake (PRA, PazO.05; plasma aldosterone,
P<0.005). In addition, the mean PRA and plasma aldo-
sterone concentration in the period of low sodium intake
was significantly higher in both the supine position (PRA,
P<0.OOl; plasma aldosterone, P<0.025) and after two
hours of ambulation (PRA, P<0.05; plasma aldosterone,
P<0.OOl) than in the period of high sodium intake. The
relationship between mean PRA and plasma aldosterone,
supine and upright on high and low sodium intake, is
shown in Fig. 3. Further examination of the relationship
between PRA and plasma aldosterone using the ungrouped
data (N=42) in both periods of high and low sodium
intake shows a significant linear correlation (r=0.329,
P<0.05). Spearman's rank correlation coefficient for the
same ungrouped data was 0.482, P<0.005.
There was no significant difference between the serum
potassium concentrations in the periods of high and low
sodium intake. All patients exhibited excellent allograft
function, as shown by the serum creatinine concentration
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Fig. 3 Relationship of plasma aldosterone concentration to PRA
in renal transplant recipients. Data shown are means SEM.
of 1.1± SD 0.3 mg/100 ml in the period of high sodium
intake and 1.2± SD 0.3 mg/lOU ml in the period of low
sodium intake. There was no demonstrable difference
between cadaveric and sibling allograft recipients or
between patients receiving low doses of prednisone and
those treated with azathioprine alone.
Discussion
In our earlier studies on anephric patients, including
seven of the 12 subjects whose data are presented in this
report, we identified three patients who exhibited an in-
crease in the concentration of plasma aldosterone after
two hours of ambulation, although, for the group, dif-
ferences between the supine and postambulatory concentra-
tions were not significant [1]. The additional data provided
by the larger group of patients included in the present
studies corroborate these findings; mean concentrations
of plasma aldosterone, supine and postambulatory on the
third or fourth day postdialysis, were identical (supine,
12.5 ng/100 ml; upright, 12.6 ng/100 ml). Moreover, the
highly significant correlation between the change in plasma
aldosterone concentration and the change in serum potas-
sium concentration in individual patients on the third or
fourth day postdialysis (Fig. 2) suggests that any change
in the concentration of plasma aldosterone occurring in
the present group of patients during periods of altered
posture and activity may be attributed to individual
variations in the serum potassium concentration.
A 0.5 mEq/liter or greater change (increase or decrease)
in the serum potassium concentration after two hours of
ambulation was noted in five of the patients studied on the
third or fourth day postdialysis. Since there was no change
in potassium balance, these changes in serum potassium
concentration must have reflected a net movement of
potassium either into or out of cells. Two factors that might
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have contributed to an increase in the serum potassium
T concentration during ambulation are the increase in
_______________________ skeletal muscle activity and the glycogenolytic effect of
epinephrine. The latter, however, could also produce an
increase in the plasma glucose concentration, which, by
stimulating an insulin response, would lower the serum
potassium concentration by shifting potassium into cells.
Regardless of the actual mechanism, the cells most likely
to be involved in this postulated shifting of potassium are
those of the liver and skeletal muscles. Whether intra-
cellular potassium in the zona glomerulosa may have
changed reciprocally or directly with the serum potassium
concentration in these studies is not known. However,
studies by Baumber et al [11] have suggested that aldo-
I I I sterone biosynthesis and adrenal cortical tissue potassium
content are directly related. Thus, it seems likely in our
studies that intracellular zona glomerulosa potassium con-
centration may have followed the serum potassium con-
centration and that changes in plasma aldosterone con-
centration during two hours of ambulation may have been
related to changes in adrenal cortical tissue potassium
content. Obviously, additional studies are needed to further
elucidate this mechanism.
Studies by Cannon, Ames and Laragh have demonstrated
that aldosterone secretion is stimulated by incremental
changes in potassium intake, and that the magnitude of
aldosterone responsiveness to potassium administration
can be directly related to the prior rate of aldosterone
production [121. Thus, heightened sensitivity of the aldo-
sterone secretory mechanism to changes in potassium might
be expected in our studies on the third or fourth day post-
dialysis when the serum potassium and plasma aldosterone
concentrations were both significantly increased. The lack
of significant correlation between serum potassium and
plasma aldosterone concentrations on the first day post-
dialysis may also be related to the fact that plasma aldo-
sterone concentrations were frequently at or near the lower
level of sensitivity of the assay.
The increase in the concentration of plasma aldosterone
produced by two hours of quiet standing in the studies on
anephric patients reported by Mitra et al [21 was apparently
unrelated to the serum potassium concentration. However,
a significant reduction in the mean arterial blood pressure
during quiet standing was also noted in these studies, which
raises the possibility that hepatic blood flow was reduced
and that the increase in the concentration of plasma aldo-
sterone was due to decreased metabolic clearance, and not
to increased secretion of aldosterone [131. Studies by
Culbertson et al [14] have shown that quiet erect posture
(75° upright tilting) may be associated with a 40 per cent
reduction in hepatic blood flow in normal subjects, even
in the absence of significant changes in mean arterial blood
pressure. Bougas et al [15] reported that under similar
conditions the metabolic clearance rate (MCR) of aldo-
sterone was approximately halved. The change in posture
from supine to quiet standing was also associated with a
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23 per cent reduction in the MCR of aldosterone in the
studies of Balikian et al [161. Whether decreased metabolic
clearance could explain the magnitude of the increase in
plasma aldosterone concentration reported by Mitra et al
[2] is uncertain. However, it seems reasonable to assume
that at least a portion of this increase may have been
attributable to this mechanism. This does not exclude the
possibility that protracted quiet standing, in contrast with
ambulation, induces changes in aldosterone secretion which
are due to increased elaboration of ACTH. An increase in
plasma cortisol concentration and a positive correlation
between the increment in plasma cortisol and the increment
in plasma aldosterone in these studies suggests that in-
creased elaboration of ACTH may indeed play a role.
Increased sensitivity of the zona glomerulosa to ACTH
after acute volume depletion induced by hemodialysis has
been postulated by McCaa et al [3]. It is also possible that
decreased metabolic clearance of aldosterone due to a
reduction in hepatic blood flow may have contributed to
the increase in plasma aldosterone concentration in these
studies. Another contributing factor may have been the
reduction in plasma sodium concentration (10 mEq/liter),
although studies on dogs with isolated adrenals by Davis,
Urquhart and Higgins [17] have suggested that larger
reductions in plasma sodium concentration may be neces-
sary to produce an increase in aldosterone production.
Gradual volume depletion induced by hypertonic pen-
toneal dialysis, which was accompanied by an increase
rather than a decrease in the plasma sodium concentration,
was not accompanied by an increase in plasma aldosterone
concentration in the studies of Mitra et al [2].
In contrast with the anephric patients in our studies, the
renal transplant recipients significantly elevated the con-
centration of plasma aldosterone after two hours of
ambulation during periods of both high and low sodium
intake. Similar observations were reported in a preliminary
communication by McCaa et al [18]. Moreover, the con-
centration of plasma aldosterone detected and the varia-
tions in concentration associated with postural changes were
similar to the data reported previously from studies on
normal individuals [1, 16, 19]. Seven of these patients had
received kidneys from cadaveric donors and were treated
with large amounts of prednisone in the early posttransplant
period. The sibling transplant recipient who was receiving
prednisone when these studies were performed (P. K.) had
also reçéived larger doses of prednisone previously during
a minor episode of threatened rejection. Thus, eight of the
patients studied had received prednisone in amounts that
were sufficient to suppress the pituitary release of ACTH.
Despite this, the plasma aldosterone concentrations and
responses to varied posture and sodium intake in these
patients could not be distinguished from those of the
remaining three patients who had not received prednisone.
There was no correlation between the plasma aldo-
sterone concentration and the serum potassium concentra-
tion in the renal transplant recipients. Instead, the correla-
tion of plasma aldosterone with PRA suggests that restora-
tion of the renin-angiotensin system results in re-orienta-
tion of the aldosterone secretory mechanism to volume-
related stimuli. All of the patients had been nephrectomized
several weeks or months prior to renal transplantation
and, consequently, the only major source of renin was the
transplanted kidney. However, the data from these and
previous studies [5, 7, 8] suggest that renin is released from
the transplanted kidney in what appears to be an essentially
normal response to sodium restriction and upright posture.
The normal pattern of response of aldosterone in these
patients may therefore be attributed to the presence of the
renin-angiotensin system, which distinguishes these patients
from the anephric individuals whose aldosterone secretory
mechanism appears to be primarily responsive to changes
in potassium.
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